Why FDA Approval Isn’t the Finish Line for MedTech Startups
MedTech Unboxed: Presented by Chamfr
What does it really take for a MedTech startup to move from FDA approval to commercialization?
In this episode of MedTech Unboxed, Steve Maxson talks with Ryan Blasko, Vice President of The Mullings Group, about why regulatory clearance is no longer the finish line for early-stage medical device companies.
Ryan breaks down the importance of reimbursement strategy, market access, society adoption, commercial operators, quality systems, and simple product demonstrations that help investors, physicians, and strategic partners understand why a technology matters.
If you’re building, funding, advising, or commercializing a MedTech startup, this episode is a practical look at what needs to happen beyond the 510(k), the pitch deck, or the first technical milestone.
Loading